Law is introduced in US Congress to give access to details of clinical trialsBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7473.996-d (Published 28 October 2004) Cite this as: BMJ 2004;329:996
- Bob Roehr
- Washington, DC
Public access to information on clinical trials and their outcomes would become universal and unfettered in the United States under a proposed law that was introduced in the House of Representatives and the Senate earlier this month.
The Fair Access to Clinical Trials Act would require registration of all human clinical trials involving drugs, “biologics” (blood products, vaccines, gene therapy tissue, and so on), and medical devices at an online database operated by the National Institutes of Health (http://www.clinicaltrials.gov/).
It would require institutional review boards to deny a trial a stamp of approval unless it was registered in the database. And …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial